Vibegron (brand name: Gemtesa) is the latest drug used to treat overactive bladder that has been approved by the FDA in the USA. Gemtesa will be available in the US as prescription-only medication from April 2021. In this post, I will summarise:
- Licensed use and legal status of vibegron (US)
- It’s a mechanism of action
- The effectiveness of vibegron: summary of clinical trial
- vibegron vs mirabegron: what is the difference?
- Alternative drugs used in the treatment of overactive bladder in the UK